Moderna produces Covid-19 shot targeting variant discovered in SA
Moderna produces Covid-19 shot targeting variant discovered in SA The US biotech is preparing for a clinical trial to gauge the effectiveness of the vaccine on 501.V2 strain 25 February 2021 - 19:55 By Hannah Kuchler Moderna has become the first vaccine maker to produce a Covid-19 shot targeted at the virus variant discovered in SA. It will ship the doses to the US National Institutes of Health (NIH) for a clinical trial. The Boston-based biotech is taking a three-pronged strategy to address concerns that its vaccine, with several others, is less effective against the 501.V2 str...